ArticleFrontiers in medicine2026
Dynamic analysis of 22 serum biomarkers following pneumothorax.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pneumothorax is a common respiratory emergency. Current diagnosis primarily relies on imaging examinations, but these have insufficient sensitivity for early or occult cases, and there is a lack of highly specific molecular markers. Investigating the dynamic changes in serum biomarkers is of great significance for the early diagnosis and intervention of pneumothorax. Methods: A rat pneumothorax model was established. Serum was collected before modeling and at 1, 2, 6, 12, 24, and 48 h after modeling. Using pre-modeling rat serum marker levels as a baseline, 22 biomarkers (including inflammatory factors, fibrosis-related molecules, immunomodulatory molecules, and metabolic indicators) were detected using enzyme-linked immunosorbent assay (ELISA). Small animal ultrasound was used to verify model establishment. Results: The rat pneumothorax model was successfully established, with ultrasound showing the loss of the lung sliding sign. The biomarkers exhibited four dynamic patterns: (1) Early rapid increase in pro-inflammatory factors (tumor necrosis factor- Conclusion: This study systematically delineates the dynamic evolution patterns of multiple classes of serum biomarkers following pneumothorax. The novel finding of abnormal elevations in TRACP, ICAM-1, and NF-κB challenges traditional understanding of their functions and provides new potential candidate targets for the early diagnosis of pneumothorax.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.